SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan

10.2337/dc14-2441

10.1016/S2213-8587(16)00052-8

10.1007/s13340-014-0164-0

Kashiwagi A, 2015, Japan Pharmacol Ther, 43, 85

10.1111/dom.12325

10.1007/s13300-014-0086-7

10.1185/03007995.2014.912983

10.1507/endocrj.EJ15-0097

10.1186/1475-2840-13-65

10.1517/14656566.2014.887680

10.1517/14656566.2014.935764

10.1111/jdi.12266

10.1007/s12325-015-0198-0

Abe M, 2014, J Japan Diabetes Soc, 57, 843

Suemaru D, 2016, J Japan Diabetes Soc, 59, 435

10.1111/jdi.12330

10.1056/NEJMoa1504720

10.1016/0168-8227(95)01064-K

10.2337/diacare.22.6.920

10.1210/jc.2011-0622

10.1253/circj.66.987

10.1136/bmj.317.7160.703

10.1056/NEJMoa0802743

Tanaka M, 2016, J Japan Diabetes Soc, 59, 188

10.2337/dc14-0093

10.1536/ihj.54.93

Nishio S, 2015, Diabetes Metab Syndr Obes, 8, 163

10.14740/jocmr2417w

10.14740/jocmr2492w

10.1517/14656566.2016.1145668

10.1111/jdi.12453

10.1111/dom.12481

10.1111/dom.12611

10.1007/s12325-016-0291-z

Utsunomiya K, 2016, J Diabetes Investig

10.1111/dom.12149

10.1186/s12933-016-0407-4

10.2337/dc14-1237

10.1186/s12933-016-0381-x

10.1111/dom.12464

Shinozaki M, 2016, J Japan Diabetes Soc, 59, S223

Shibata S, 2014, J Japan Diabetes Soc, 57, 885

Ito H, 2015, Geriatr Gerontol Int

10.2337/dc12-1503

Wanner C, 2016, N Engl J Med

10.1007/s13300-013-0029-8

Ito H, 2015, Expert Opin Pharmacother, 16, 289, 10.1517/14656566.2015.995091

10.2337/dc13-0323

10.1111/1744-9987.12378

10.1093/ndt/gfp579

10.1016/j.jdiacomp.2012.04.011

10.1159/000353592

10.2337/dc16-0041

10.1517/13543784.2011.539558

10.1056/NEJMoa1307684

10.1056/NEJMoa1305889

10.1056/NEJMoa1501352

10.1136/bmj.i610

10.1186/1475-2840-9-18

10.2337/dc15-0781

10.2337/dc15-2145

Marso SP, 2016, N Engl J Med